Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-712

The big problem with this analysis is that, according to the term sheet for the recent cap raise, the sophisticated investors get their hands on their shares tomorrow.

What happens when a sophie gets the opportunity to take a 35% stag profit on shares he/she has paid for less than a week ago?

Adding 23 million shares to the sell side is going to put some pressure on the price. We'd better hope Maria puts out a ball-tearer of an announcement first.